by Five Rivers Rx | Apr 2, 2020 | Industry News
In our last Special Edition, we covered how manufacturing capacity around the globe is likely being affected, the implementation of force majeure contract clauses, and how increased pressure on the supply chain will play out (read here). This week, we provide more...
by Five Rivers Rx | Mar 24, 2020 | Drug Manufacturers
With the developments around COVID-19, the drug manufacturers that are working on a cure for the virus have been praised as (potential) saviors across the globe. This is a stark change to how they have regarded over the last few years – drug manufacturers have...
by Five Rivers Rx | Mar 12, 2020 | Industry News
As the coronavirus wreaks havoc around the globe, the pharmaceutical supply chain needs to prepare for an exceptionally tumultuous ride. Around the World As the virus spreads across the world, countries are taking drastic preventative measures to prevent the spread of...
by Five Rivers Rx | Mar 12, 2020 | DEA, Suspicious Order Monitoring
The settlement between the California Board of Pharmacy and AmerisourceBergen demonstrates the importance of embracing Suspicious Order Monitoring as a systematic and procedural Background The California Board of Pharmacy settled its longstanding investigation of...
by Five Rivers Rx | Feb 27, 2020 | Industry News
How Telemedicine Has Made Generic Drugs Sexy Since 2017, Direct-to-Consumer (DTC) startups (some engaged by Five Rivers RX!) have cropped up to market and supply drugs to patients across the United States. The product portfolio is not too exciting – including generic...
